ReviewInflammopharmacology2024

Epi-revolution in rheumatology: the potential of histone deacetylase inhibitors for targeted rheumatoid arthritis intervention.

Padmini Pai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.